http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-0212080-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-605
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-715
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-605
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
filingDate 2002-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cefcbd88c0c94a33eaa66317669969f9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f27747e396f6a002d0db5214396aeb43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c75155ae4690d59ba0297c15d1c99bda
publicationDate 2006-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-0212080-A
titleOfInvention glp-1 compound, method of glp-1 receptor stimulation in an individual in need of such stimulation, and use of a glp-1 compound
abstract "GLP-1 COMPOUND, GLP-1 RECEIVER STIMULATION METHOD IN AN INDIVIDUAL REQUIRING SUCH STIMULATION, AND USE OF A GLP-1 COMPOUND". Glucagon-like peptide-1 (GLP-1) compounds having modifications at one or more of the following positions are described: 7, 8, 12, 16, 18, 19, 20, 22, 25, 27, 30, 33, and 37. Methods of treating an individual in need of GLP-1 receptor stimulation using these GLP-1 compounds are also described.
priorityDate 2001-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422601242
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396196
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID397595
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID14526
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3772194
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3771769
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID280802
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID373686
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2641
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID494052
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16133831
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3772480

Total number of triples: 39.